Native Orthopaedics, a startup founded by Anderson and Gamache, has introduced a revolutionary technology in sports medicine. The company has developed a knotless, retensionable suture system that allows surgeons to repair critical ligaments and tendons with precision and reliability.
Traditional methods involve threading sutures through torn tissue and tying knots, which can be unreliable and lead to complications. Native Orthopaedics’ technology, likened to a zip tie for tissue repair, allows surgeons to adjust tension and position in real-time during surgery, ensuring a more accurate and effective repair.
The company recently won a $75,000 innovation award and has secured close to $3 million in funding, with over 80% of investors being surgeons impressed by the product’s potential. They are in the process of obtaining FDA approval and plan to launch the product in 2025.
Once approved, the company aims to revolutionize the treatment of sports injuries by providing surgeons with a predictable and efficient procedure that ensures optimal outcomes. The technology simplifies the repair process and enhances the healing potential by creating a secure biological connection between tissue and bone.
In summary, Native Orthopaedics’ innovative suture system offers a game-changing solution for surgeons treating sports injuries, providing a reliable and adjustable method for tissue repair. With FDA approval on the horizon, the company is poised to make a significant impact on the field of sports medicine.
Source
Note: The image is for illustrative purposes only and is not the original image associated with the presented article. Due to copyright reasons, we are unable to use the original images. However, you can still enjoy the accurate and up-to-date content and information provided.